Fresenius Medical Care (FMS) said Tuesday that it targets to reach mid-teens percentage in operating income margins by 2030 through its FME Reignite strategy.
The company said it has estimated 1.05 billion euros ($1.21 billion) in sustainable savings by the end of 2027 from its extended FME25 program, which it expects to help support its targeted operating income margins.
Fresenius' chief financial officer, Martin Fischer, said the company plans to allocate 800 million euros to 1 billion euros for capital expenditures annually for 2025 to 2030 to invest in its core business.
Additionally, Fresenius said it is starting a new share buyback program this year, with initial share repurchases of 1 billion euros over two years.
Shares of Fresenius were down more than 3% in recent premarket activity Tuesday.